PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that on October 31, 2014 the Centers for Medicare and Medicaid Services (CMS) issued the final rule for hospital outpatient prospective payment to take effect January 1, 2015. Included in the final rule are payment amounts associated with the use of the Company’s TCC-EZ® Total Contact Cast and its AMNIOEXCEL® skin substitute product.
Help employers find you! Check out all the jobs and post your resume.
